124 related articles for article (PubMed ID: 37688931)
21. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies.
Broeders M; Moss S; Nyström L; Njor S; Jonsson H; Paap E; Massat N; Duffy S; Lynge E; Paci E;
J Med Screen; 2012; 19 Suppl 1():14-25. PubMed ID: 22972807
[TBL] [Abstract][Full Text] [Related]
22. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
[TBL] [Abstract][Full Text] [Related]
23. A population health assessment of screening mammography on breast cancer mortality in North Carolina.
Burch AE; Irish WD; Wong JH
Breast Cancer Res Treat; 2022 Dec; 196(3):647-656. PubMed ID: 36287307
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors and outcomes in women with breast cancer in Slovenia in relation to step-wise implementation of organized screening.
Tomšič S; Žagar T; Mihor A; Mlakar M; Lokar K; Jarm K; Zadnik V
PLoS One; 2022; 17(11):e0278384. PubMed ID: 36449489
[TBL] [Abstract][Full Text] [Related]
25. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
26. Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines.
Guo F; Kuo YF; Berenson AB
Am J Prev Med; 2019 Jan; 56(1):100-108. PubMed ID: 30573138
[TBL] [Abstract][Full Text] [Related]
27. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies.
Moss SM; Nyström L; Jonsson H; Paci E; Lynge E; Njor S; Broeders M;
J Med Screen; 2012; 19 Suppl 1():26-32. PubMed ID: 22972808
[TBL] [Abstract][Full Text] [Related]
28. Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.
Zielonke N; Gini A; Jansen EEL; Anttila A; Segnan N; Ponti A; Veerus P; de Koning HJ; van Ravesteyn NT; Heijnsdijk EAM;
Eur J Cancer; 2020 Mar; 127():191-206. PubMed ID: 31932175
[TBL] [Abstract][Full Text] [Related]
29. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
[TBL] [Abstract][Full Text] [Related]
30. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
31. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
Swedish Organised Service Screening Evaluation Group
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
33. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
34. Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.
Weedon-Fekjær H; Bakken K; Vatten LJ; Tretli S
BMJ; 2012 Jan; 344():e299. PubMed ID: 22290099
[TBL] [Abstract][Full Text] [Related]
35. RE: Breast Cancer Mortality After Implementation of Organized Population-Based Screening in Norway.
Zahl PH
J Natl Cancer Inst; 2020 Nov; 112(11):1174. PubMed ID: 32986840
[No Abstract] [Full Text] [Related]
36. Breast cancer screening and the changing population pyramid of Japan.
Uchida K; Ohashi H; Kinoshita S; Nogi H; Kato K; Toriumi Y; Yamashita A; Kamio M; Mimoto R; Takeyama H
Breast Cancer; 2015 Mar; 22(2):172-6. PubMed ID: 23625276
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer mortality in Norway after the introduction of mammography screening.
Olsen AH; Lynge E; Njor SH; Kumle M; Waaseth M; Braaten T; Lund E
Int J Cancer; 2013 Jan; 132(1):208-14. PubMed ID: 22532175
[TBL] [Abstract][Full Text] [Related]
38. Screening outcome for consecutive examinations with digital breast tomosynthesis versus standard digital mammography in a population-based screening program.
Hovda T; Brandal SHB; Sebuødegård S; Holen ÅS; Bjørndal H; Skaane P; Hofvind S
Eur Radiol; 2019 Dec; 29(12):6991-6999. PubMed ID: 31187221
[TBL] [Abstract][Full Text] [Related]
39. Health Care Accessibility and Breast Cancer Mortality in Europe.
Ciuba A; Wnuk K; Nitsch-Osuch A; Kulpa M
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294189
[TBL] [Abstract][Full Text] [Related]
40. Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.
Viel JF; Rymzhanova R; Fournier E; Danzon A
Cancer Epidemiol; 2011 Dec; 35(6):521-5. PubMed ID: 21621498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
